CTNNB1 and cancer: Thus, these reprogrammed hepatocytes are an intermediate cell phenotype, likely reflecting cancer cell differentiation to normal hepatocyte-like cells and contributing to the rapid cell turnover observed following LNP-CTNNB1 treatment.